EUVIMEDObjevte EUVIMED
Crossref

Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease

Efe Doğukan Dincel iD, Faika Başoğlu-Ünal iD, Ebru Didem Kuran, Tülay Kayra, Nurcan Aydın, Esmanur Kanber, İlhami Gülçin, Nuray Ulusoy-Güzeldemirci

Chemical Biology & Drug Design · 2024-02 · 103 (2)

DOI: 10.1111/cbdd.14482 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2024-02-20. Written by Efe Doğukan Dincel and 7 co-authors. Institution: Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul University, Istanbul, Turkey. Major MEDLINE topics: Carbonic Anhydrases, Alzheimer Disease. Cited 14 times so far (Crossref); 33 references. Funded by: Istanbul Üniversitesi.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

In this project, non‐sulfonamide bistrifluoromethyl‐derived hydrazide‐hydrazones were synthesized as multi‐target‐directed ligands to treat Alzheimer's disease and then, the novel derivatives were characterized by diverse spectral methods. Acetylcholinesterase (AChE), and human carbonic anhydrase (hCA) inhibitory qualifications of these compounds were determined. The reported compounds ( 2a ‐ y ) were determined to be effective inhibitors of the hCA I, hCA II and AChE enzymes with K i values in the range of 1.130 ± 0.15–5.440 ± 0.93 μM for hCA I, 0.894 ± 0.05–6.647 ± 1.35 μM for hCA II, and 0.196 ± 0.03–4.222 ± 1.04 μM for AChE. In silico studies were also performed to illuminate the binding interactions.

Subjects

MeSH terms (MEDLINE)

Carbonic AnhydrasesAlzheimer DiseaseHumansAcetylcholinesteraseCarbonic Anhydrase InhibitorsCholinesterase InhibitorsHydrazonesStructure-Activity RelationshipMolecular Structure

Author keywords

acetylcholinesterasecarbonic anhydrasehydrazide-hydrazonemolecular dockingsynthesis

Substances

AcetylcholinesteraseCarbonic AnhydrasesCarbonic Anhydrase InhibitorsCholinesterase InhibitorsHydrazones

Authors and institutions

  • Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul University, Istanbul, Turkey.
  • Faculty of Pharmacy, Department of Pharmaceutical Chemistry, European University of Lefke, Mersin, Turkey.
  • Faculty of Science, Department of Chemistry, Atatürk University, Erzurum, Turkey.

ORCID profiles: Efe Doğukan Dincel, Faika Başoğlu-Ünal

Funding

  • Istanbul Üniversitesi

Cite

APA

Dincel, E. D., Başoğlu-Ünal, F., Kuran, E. D., Kayra, T., Aydın, N., Kanber, E., Gülçin, İ., & Ulusoy-Güzeldemirci, N. (2024). Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease. Chemical Biology & Drug Design, 103(2). https://doi.org/10.1111/cbdd.14482

Vancouver

Dincel ED, Başoğlu-Ünal F, Kuran ED, Kayra T, Aydın N, Kanber E, et al. Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease. Chemical Biology & Drug Design. 2024;103(2). doi:10.1111/cbdd.14482

BibTeX
@article{Dincel2024,
  author = {Dincel, Efe Doğukan and Başoğlu-Ünal, Faika and Kuran, Ebru Didem and Kayra, Tülay and Aydın, Nurcan and Kanber, Esmanur and Gülçin, İlhami and Ulusoy-Güzeldemirci, Nuray},
  title = {Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  volume = {103},
  number = {2},
  doi = {10.1111/cbdd.14482}
}
Start for free →